MYR Pharmaceuticals Logo (WIPO, 26.10.2020)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke MYR Pharmaceuticals wurde als Bildmarke am 26.10.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.
Logodesign (Wiener Klassifikation)
#Dreiecke, Linien, die einen Winkel bilden #Briefe, die eine besondere Form des Schreibens darstellen #Farben #Ein Dreieck #Dreieckige Figuren mit einem oder mehreren abgeschnittenen oder abgerundeten Winkeln #Dreiecke, die einen oder mehrere Buchstaben enthalten #Buchstabenreihen in verschiedenen Dimensionen #Serien von Buchstaben, die nicht durch ein einzelnes Leerzeichen voneinander getrennt sind #Drei vorherrschende Farben
| Markenform | Bildmarke |
| Aktenzeichen | 1591282 |
| Registernummer | 302020105510 |
| Länder | 
|
| Basismarke |
Nr. 30 2020 105 510,
17. August 2020
|
| Anmeldedatum | 26. Oktober 2020 |
| Ablaufdatum | 26. Oktober 2030 |
Markeninhaber
Burgwedel,
Fraunhoferstr. 17
DE
Fraunhoferstr. 17
DE
Markenvertreter
Attn: Gretchen R. Stroud,
333 Lakeside Drive
US
Waren und Dienstleistungen
01
Chemicals for use in industry and science; peptides
substrates for scientific and industrial purposes;
oligopeptides; polypeptides; proteins [raw material];
polynucleotides [chemicals for scientific purposes];
oligonucleotides [chemicals for scientific purposes];
nucleic acids; SiRNA molecules; small molecules having a
molar mass of 160 to 480 [for scientific purposes]
05
Pharmaceutical and veterinary preparations; biological
preparations for medical purposes; biological preparations
for veterinary purposes; biochemical preparations for
medical purposes; biochemical preparations for veterinary
purposes; chemical preparations for medical purposes;
chemical preparations for veterinary purposes; medicines for
medical purposes; medicines for veterinary purposes;
pharmaceutical preparations for treating liver diseases and
disorders; pharmaceutical products for hepatitis B;
pharmaceutical products for hepatitis D; pharmaceutical
preparations for dyslipidemia; pharmaceutical preparations
for nonalcoholic steatohepatitis [NASH]; pharmaceutical
preparations for primary biliary cholangitis [PBC];
pharmaceutical preparations for inflammatory diseases;
pharmaceutical preparations for inflammatory diseases
inhibiting sodium-taurocholate co-transporting polypeptide
[NTCP]; pharmaceutical preparations for the treatment of
metabolic diseases; pharmaceutical preparations for the
treatment of metabolic diseases inhibiting
sodium-taurocholate co-transporting polypeptide [NTCP]
09
Scientific, surveying, weighing, measuring apparatus and
instruments; apparatus and instruments for scientific
research, in particular scientific research in laboratories;
data processing apparatus; computers; CDs; DVDs; digital
recording media; computer software
42
Scientific and technological services and research and
design relating thereto; industrial analysis services;
industrial research services; scientific research for
medical, chemical, biological, veterinary and pharmaceutical
purposes; scientific and technological services and research
and design related thereto in the field of hepatitis B;
scientific and technological services and research and
design related thereto in the field of hepatitis D;
scientific and technological services and research and
design related thereto in the field of dyslipidemia;
scientific and technological services and research and
design related thereto in the field of nonalcoholic
steatohepatitis [NASH]; scientific and technological
services and research and design related thereto in the
field of primary biliary cholangitis [PBC]; scientific and
technological services and research and design related
thereto in the field of inflammatory diseases; scientific
and technological services and research and design related
thereto in the field of inflammatory diseases inhibiting
sodium-taurocholate co-transporting polypeptide [NTCP];
scientific and technological services and research and
design related thereto in the field of metabolic diseases;
scientific and technological services and research and
design related thereto in the field of metabolic diseases
inhibiting sodium-taurocholate co-transporting polypeptide
[NTCP]; design and development of computer hardware and
software; scientific and technological services in the field
of preclinical development, in particular related to
hepatitis B, hepatitis D, dyslipidemia, nonalcoholic
steatohepatitis [NASH], inflammatory diseases, inflammatory
diseases inhibiting sodium-taurocholate co-transporting
polypeptide [NTCP], primary biliary cholangitis [PBC],
metabolic diseases, and metabolic diseases inhibiting
sodium-taurocholate co-transporting polypeptide [NTCP];
scientific and technological services in the field of
clinical development, in particular related to hepatitis B,
hepatitis D, dyslipidemia, nonalcoholic steatohepatitis
[NASH], primary biliary cholangitis [PBC], inflammatory
diseases, inflammatory diseases inhibiting
sodium-taurocholate co-transporting polypeptide [NTCP],
metabolic diseases, and metabolic diseases inhibiting
sodium-taurocholate co-transporting polypeptide [MVP]
44
Medical services; veterinary services; medical and
veterinary services, in particular medical analysis in
connection with the treatment of individuals; providing
information in the medical field, veterinary field and
pharmacology; services of health centres; services of
clinics (ambulances); therapy services; hygienic and beauty
care for human beings and animals
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 20. Juni 2023 | 2023/25 Gaz | PH | Ablehnung |
| 22. Februar 2023 | 2023/11 Gaz | KH | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 30. Dezember 2022 | 2023/6 Gaz | AM | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 29. November 2022 | 2022/48 Gaz | NZ | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 19. November 2022 | 2022/48 Gaz | UZ | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 09. November 2022 | 2022/45 Gaz | TH | Ablehnung |
| 07. November 2022 | 2022/47 Gaz | CU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 31. Oktober 2022 | 2022/44 Gaz | WS | Ablehnung |
| 26. Oktober 2022 | 2022/43 Gaz | IS | Ablehnung |
| 25. Oktober 2022 | 2022/44 Gaz | AL | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 19. Oktober 2022 | 2022/42 Gaz | TM | Ablehnung |
| 14. Oktober 2022 | 2022/43 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 17. September 2022 | 2022/39 Gaz | RAW: Limitation | |
| 14. September 2022 | 2022/39 Gaz | KH | Ablehnung |
| 30. August 2022 | 2022/39 Gaz | MD | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 26. August 2022 | 2022/39 Gaz | TJ | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 25. August 2022 | 2022/35 Gaz | BA | Ablehnung |
| 25. August 2022 | 2022/36 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 24. August 2022 | 2022/34 Gaz | CA | Ablehnung |
| 10. August 2022 | 2022/32 Gaz | ID | Ablehnung |
| 08. August 2022 | 2022/35 Gaz | PH | Ablehnung |
| 27. Juli 2022 | 2022/34 Gaz | RAW: Limitation | |
| 04. Juli 2022 | 2022/31 Gaz | IL | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 01. Juli 2022 | 2022/28 Gaz | KZ | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 01. Juli 2022 | 2022/26 Gaz | MX | Ablehnung |
| 14. Juni 2022 | 2022/27 Gaz | GE | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 02. Juni 2022 | 2022/23 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 31. Mai 2022 | 2022/22 Gaz | LA | Ablehnung |
| 25. Mai 2022 | 2022/22 Gaz | MY | Ablehnung |
| 20. Mai 2022 | 2022/28 Gaz | KP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 17. Mai 2022 | 2022/22 Gaz | UZ | Ablehnung |
| 12. Mai 2022 | 2022/23 Gaz | AL | Ablehnung |
| 11. Mai 2022 | 2022/19 Gaz | LI | Ablehnung |
| 11. Mai 2022 | 2022/20 Gaz | VN | Ablehnung |
| 06. Mai 2022 | 2022/20 Gaz | AM | Ablehnung |
| 28. April 2022 | 2022/19 Gaz | CU | Ablehnung |
| 25. April 2022 | 2022/17 Gaz | RU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 20. April 2022 | 2022/21 Gaz | MN | Ablehnung |
| 12. April 2022 | 2022/15 Gaz | CH | Ablehnung |
| 11. April 2022 | 2022/15 Gaz | OA | Ablehnung |
| 06. April 2022 | 2022/17 Gaz | BW | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 01. April 2022 | 2022/15 Gaz | TJ | Ablehnung |
| 25. März 2022 | 2022/13 Gaz | ME | Ablehnung |
| 25. März 2022 | 2022/13 Gaz | MD | Ablehnung |
| 23. März 2022 | 2022/14 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 22. März 2022 | 2022/12 Gaz | NO | Ablehnung |
| 13. März 2022 | 2022/11 Gaz | UA | Ablehnung |
| 05. März 2022 | 2022/11 Gaz | AZ | Ablehnung |
| 03. März 2022 | 2022/9 Gaz | JP | Ablehnung |
| 28. Februar 2022 | 2022/9 Gaz | KR | Ablehnung |
| 24. Februar 2022 | 2022/9 Gaz | BN | Ablehnung |
| 18. Februar 2022 | 2022/9 Gaz | KZ | Ablehnung |
| 17. Februar 2022 | 2022/8 Gaz | GE | Ablehnung |
| 15. Februar 2022 | 2022/7 Gaz | SX | Ablehnung |
| 28. Januar 2022 | 2022/5 Gaz | KG | Ablehnung |
| 20. Januar 2022 | 2022/11 Gaz | MG | Ablehnung |
| 20. Januar 2022 | 2022/3 Gaz | CO | Ablehnung |
| 29. Dezember 2021 | 2021/52 Gaz | GB | Ablehnung |
| 20. Dezember 2021 | 2021/51 Gaz | CW | Ablehnung |
| 06. Dezember 2021 | 2021/49 Gaz | DZ | Ablehnung |
| 03. Dezember 2021 | 2021/49 Gaz | MC | Ablehnung |
| 23. November 2021 | 2021/47 Gaz | BR | Ablehnung |
| 18. November 2021 | 2021/46 Gaz | BT | Ablehnung |
| 18. November 2021 | 2021/46 Gaz | SY | Ablehnung |
| 17. November 2021 | 2021/46 Gaz | SM | Ablehnung |
| 12. November 2021 | 2021/47 Gaz | KP | Ablehnung |
| 10. November 2021 | 2021/45 Gaz | BY | Ablehnung |
| 09. November 2021 | 2021/45 Gaz | RS | Ablehnung |
| 22. Oktober 2021 | 2021/44 Gaz | NA | Ablehnung |
| 20. Oktober 2021 | 2021/42 Gaz | TR | Ablehnung |
| 06. Oktober 2021 | 2021/40 Gaz | EM | Ablehnung |
| 30. September 2021 | 2021/40 Gaz | MN | Ablehnung |
| 29. September 2021 | 2021/40 Gaz | IL | Ablehnung |
| 07. September 2021 | 2021/39 Gaz | CN | Ablehnung |
| 06. September 2021 | 2021/37 Gaz | RU | Ablehnung |
| 20. August 2021 | 2021/34 Gaz | NZ | Ablehnung |
| 12. August 2021 | 2021/35 Gaz | BW | Ablehnung |
| 29. Juli 2021 | 2021/30 Gaz | AU | Ablehnung |
| 23. Juli 2021 | 2021/30 Gaz | SG | Ablehnung |
| 30. Juni 2021 | 2021/37 Gaz | RAW: Limitation | |
| 31. Mai 2021 | 2021/23 Gaz | IN | Ablehnung |
| 24. Mai 2021 | 2021/22 Gaz | US | Ablehnung |
| 23. Mai 2021 | 2021/22 Gaz | PH | Ablehnung |
| 26. Oktober 2020 | 2021/17 Gaz | DE | Eintragung |
ID: 141591282